|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
N/A
|
National Cancer Institute
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
Custer, Mary
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA008748-47S4
|
$12,328,495
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RES
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Regional Oncology Research Center
|
5P30CA006973-50
|
$6,540,575
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
Cancer Center Support Grant
|
5P30CA047904-25
|
$5,055,275
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,497,257
|
Fojo, Antonio
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
5P30CA016058-37
|
$4,284,455
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-39
|
$4,133,528
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Core Support for Cancer Center
|
2P30CA013330-40
|
$3,589,611
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Cancer Center Support Grant
|
5P30CA046934-25
|
$3,430,389
|
Theodorescu, Dan
|
UNIVERSITY OF COLORADO DENVER
|
|
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
|
2P01CA124570-06
|
$2,212,542
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
|
1P50CA168505-01A1
|
$2,150,500
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,539,189
|
Alavanja, Michael
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,117,473
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Gene expression and regulation in endocrine cancers
|
ZIA BC 011275
|
$1,104,239
|
Kebebew, Electron
|
CCR (NCI)
|
|
Therapeutic targets and novel anticancer agents for endocrine cancers
|
ZIA BC 011286
|
$883,391
|
Kebebew, Electron
|
CCR (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$833,506
|
Yang, James
|
CCR (NCI)
|
|
DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural
|
ZIA CP010144-10548
|
$668,605
|
Stewart, Douglas
|
DCEG (NCI)
|
|
Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests
|
5U01CA137026-04
|
$608,347
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY MED CTR
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133-04180
|
$508,741
|
Linet, Martha
|
DCEG (NCI)
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119-10527
|
$507,725
|
Alavanja, Michael
|
DCEG (NCI)
|
|
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer
|
1R01CA166033-01A1
|
$504,330
|
KOENIG, RONALD
|
UNIVERSITY OF MICHIGAN
|
|
Chornobyl Thyroid Study (Belarus)
|
ZIA CP010132-04019
|
$495,958
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$482,920
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$477,918
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
Chornobyl Thyroid Study (Ukraine)
|
ZIA CP010132-04173
|
$449,748
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling
|
1R01CA173592-01A1
|
$414,552
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RES
|
|
Improved diagnostic and monitoring assays for thyroid cancer
|
2R44CA150324-02
|
$391,627
|
PILLER, KENNETH
|
SOYMEDS, INC.
|
|
Thyroid Stem/Progenitor Cells
|
ZIA BC 005522
|
$385,381
|
Kimura, Shioko
|
CCR (NCI)
|
|
Molecular Pathophysiology of Thyroid Cell Growth
|
5R01CA050706-23
|
$368,104
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RES
|
|
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
|
1R01CA178007-01
|
$351,713
|
Jin, Moonsoo
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
1R01CA167839-01A1
|
$346,525
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
|
1R01CA175994-01
|
$320,329
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
PKA and follicular thyroid carcinogenesis: Roles of interacting pathways
|
1R01CA170249-01A1
|
$316,438
|
KIRSCHNER, LAWRENCE
|
OHIO STATE UNIVERSITY
|
|
Genetic analysis of the P13K/Akt pathway in thyroid benign and malignant disease
|
5R01CA128943-05
|
$314,070
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
RCAN1 in Thyroid Cancer Progression
|
5R01CA152066-03
|
$313,545
|
Ringel, Matthew
|
OHIO STATE UNIVERSITY
|
|
Molecular Events in the PI3K/Akt Pathway in Thyroid Cancer
|
5R01CA134225-05
|
$310,286
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Rap1Gap and Tumor Progression
|
5R01CA127986-05
|
$302,718
|
MEINKOTH, JUDY
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Role of BRAF Mutation in Thyroid Cancer Invasion
|
5R01CA149738-03
|
$301,154
|
Parangi, Sareh
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Intervention models for thyroid proliferative disease using a bioactive food comp
|
5R01CA131946-05
|
$300,826
|
TIWARI, RAJ
|
NEW YORK MEDICAL COLLEGE
|
|
Targeting Focal Adhesion Kinase in Thyroid Cancer
|
5R01CA164193-02
|
$299,226
|
Schweppe, Rebecca
|
UNIVERSITY OF COLORADO DENVER
|
|
Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancer
|
5R01CA151842-04
|
$294,031
|
KOENIG, RONALD
|
UNIVERSITY OF MICHIGAN
|
|
RhoB in cancer pathogenesis and as a target in combinatorial therapy
|
5R01CA136665-04
|
$293,662
|
COPLAND, JOHN
|
MAYO CLINIC JACKSONVILLE
|
|
The NFkB-dependent Secretome and Invasion/Angiogenesis in Thyroid Cancer
|
5R01CA155512-03
|
$290,901
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer
|
1R44CA171352-01A1
|
$283,958
|
Weintraub, Bruce
|
TROPHOGEN, INC.
|
|
Role of Skp2-cyclin A Interaction in Normal Physiology and Cancer
|
5R01CA131421-05
|
$282,663
|
ZHU, LIANG
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Genetic & Epigenetic Events in Papillary Thyroid Cancer
|
2R01CA113507-06A1
|
$271,198
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|